The Effects of an Antioxidant Formulation on Ocular Blood Flow
Completed · Not applicable · Has a placebo group
Conditions studied: Primary Open Angle Glaucoma
In brief
The objective is to evaluate the effects of an antioxidant formula versus placebo on ocular blood flow in a randomized double-blind, crossover design. Based upon preliminary data, it is hypothesized that a dietary supplement containing a variety of ingredients with antioxidant properties will, compared to placebo, increase ocular perfusion pressure, retrobulbar, retinal capillary and choroidal blood flow, and maintain these effects over the course of the treatment period.
Key facts
- Study ID
- NCT01930487
- Run by
- ScienceBased Health
- People needed
- 47
- Starts
- 2013-08-01
- Expected to finish
- 2015-08-01
- Last updated by the study team
- 2016-12-05
Who can join
Age: 30 and older, up to 70. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Age 30 years or older.
- Confirmed diagnosis of open angle glaucoma by glaucoma specialist in the study eye, as evidenced from criteria representative of glaucomatous optic nerve damage such as specific optic disc or retinal nerve fiber layer structural abnormalities and/or visual field abnormalities.
- Best corrected visual acuity at 20/60 or better in study eye.
- Willingness to avoid caffeine and smoking for 12 hours before and during the study visits.
You may not qualify if…
- History of acute angle-closure or a narrow, occluding of anterior chamber angle by gonioscopy.
- History of chronic or recurrent inflammatory eye diseases or signs of intraocular trauma and/or unreliable applanation tonometry.
- Severe, unstable or uncontrolled cardiovascular, renal or pulmonary disease
- History of/or current renal or hepatic impairment.
- History of/or current bronchial asthma, severe chronic obstructive pulmonary disease, sinus bradycardia, second or third degree atrioventricular block, or cardiogenic shock.
- Recent surgery or surgery planned near study timeline
- History of bleeding disorder
- Use of blood thinning medications
- Use of specified dietary supplements for three weeks prior to study entry and throughout study period.
Where it is running
- Glick Eye Institute, Ocular Vascular Research Center, Indiana University School of Medicine — Indianapolis, Indiana, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.